Psychostimulant-induced neuroadaptations in nucleus accumbens AMPA receptor transmission
- PMID: 23232118
- PMCID: PMC3552338
- DOI: 10.1101/cshperspect.a012021
Psychostimulant-induced neuroadaptations in nucleus accumbens AMPA receptor transmission
Abstract
Medium spiny neurons of the nucleus accumbens serve as the interface between corticolimbic regions that elicit and modulate motivated behaviors, including those related to drugs of abuse, and motor regions responsible for their execution. Medium spiny neurons are excited primarily by AMPA-type glutamate receptors, making AMPA receptor transmission in the accumbens a key regulatory point for addictive behaviors. In animal models of cocaine addiction, changes in the strength of AMPA receptor transmission onto accumbens medium spiny neurons have been shown to underlie cocaine-induced behavioral adaptations related to cocaine seeking. Here we review changes in AMPA receptor levels and subunit composition that occur after discontinuing different types of cocaine exposure, as well as changes elicited by cocaine reexposure following abstinence or extinction. Signaling pathways that regulate these cocaine-induced adaptations will also be considered, as they represent potential targets for addiction pharmacotherapies.
References
-
- Albin RL, Young AB, Penney JB 1989. The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366–375 - PubMed
-
- Alexander GE, Crutcher MD, DeLong MR 1990. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions. Prog Brain Res 85: 119–146 - PubMed
-
- Anderson SM, Famous KR, Sadri-Vakili G, Kumaresan V, Schmidt HD, Bass CE, Terwilliger EF, Cha JH, Pierce RC 2008. CaMKII: A biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat Neurosci 11: 344–353 - PubMed
-
- Aujla H, Beninger RJ 2003. Intra-accumbens protein kinase C inhibitor NPC 15437 blocks amphetamine-produced conditioned place preference in rats. Behav Brain Res 147: 41–48 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- DA18678/DA/NIDA NIH HHS/United States
- R01 DA009621/DA/NIDA NIH HHS/United States
- R01 DA022339/DA/NIDA NIH HHS/United States
- DA009621/DA/NIDA NIH HHS/United States
- R01 DA015214/DA/NIDA NIH HHS/United States
- DA31535/DA/NIDA NIH HHS/United States
- DA22339/DA/NIDA NIH HHS/United States
- K02 DA018678/DA/NIDA NIH HHS/United States
- DA015835/DA/NIDA NIH HHS/United States
- F31 DA031535/DA/NIDA NIH HHS/United States
- K05 DA029099/DA/NIDA NIH HHS/United States
- R01 DA015835/DA/NIDA NIH HHS/United States
- DA15214/DA/NIDA NIH HHS/United States
- R37 DA015835/DA/NIDA NIH HHS/United States
- DA029099/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical